Surgery Partners Stock Price Prediction
| SGRY Stock | USD 16.12 0.41 2.61% |
Momentum 41
Sell Extended
Oversold | Overbought |
Using Surgery Partners hype-based prediction, you can estimate the value of Surgery Partners from the perspective of Surgery Partners response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Surgery Partners to buy its stock at a price that has no basis in reality. In that case, they are not buying Surgery because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Surgery Partners after-hype prediction price | USD 16.01 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Surgery Partners Basic Forecasting Models to cross-verify your projections. Surgery Partners After-Hype Price Prediction Density Analysis
As far as predicting the price of Surgery Partners at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Surgery Partners or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Surgery Partners, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Surgery Partners Estimiated After-Hype Price Volatility
In the context of predicting Surgery Partners' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Surgery Partners' historical news coverage. Surgery Partners' after-hype downside and upside margins for the prediction period are 12.17 and 19.85, respectively. We have considered Surgery Partners' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Surgery Partners is not too volatile at this time. Analysis and calculation of next after-hype price of Surgery Partners is based on 3 months time horizon.
Surgery Partners Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Surgery Partners is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Surgery Partners backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Surgery Partners, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.25 | 3.84 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
16.12 | 16.01 | 0.68 |
|
Surgery Partners Hype Timeline
Surgery Partners is at this time traded for 16.12. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Surgery is projected to decline in value after the next headline, with the price expected to drop to 16.01. The average volatility of media hype impact on the company price is insignificant. The price decrease on the next news is expected to be -0.68%, whereas the daily expected return is at this time at -0.25%. The volatility of related hype on Surgery Partners is about 0.0%, with the expected price after the next announcement by competition of 16.12. About 99.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.21. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Surgery Partners has Price/Earnings To Growth (PEG) ratio of 1.66. The entity recorded a loss per share of 1.36. The firm had not issued any dividends in recent years. Given the investment horizon of 90 days the next projected press release will be within a week. Check out Surgery Partners Basic Forecasting Models to cross-verify your projections.Surgery Partners Related Hype Analysis
Having access to credible news sources related to Surgery Partners' direct competition is more important than ever and may enhance your ability to predict Surgery Partners' future price movements. Getting to know how Surgery Partners' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Surgery Partners may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| LIVN | LivaNova PLC | 0.00 | 0 per month | 1.32 | 0.12 | 4.27 | (2.44) | 11.23 | |
| ATEC | Alphatec Holdings | 0.00 | 0 per month | 1.15 | 0.29 | 4.31 | (2.62) | 21.03 | |
| BKD | Brookdale Senior Living | 0.00 | 0 per month | 0.87 | 0.18 | 3.51 | (1.73) | 8.55 | |
| SRRK | Scholar Rock Holding | 0.00 | 0 per month | 3.09 | 0.07 | 5.92 | (5.10) | 30.20 | |
| ARDT | Ardent Health Partners | 0.00 | 0 per month | 0.00 | (0.15) | 3.47 | (3.69) | 36.66 | |
| IDYA | Ideaya Biosciences | 0.00 | 0 per month | 1.85 | 0.17 | 4.86 | (3.57) | 14.71 | |
| HTFL | Heartflow Common Stock | 0.00 | 0 per month | 4.58 | 0.0004 | 6.49 | (6.60) | 20.72 | |
| ZLAB | Zai Lab | 0.00 | 0 per month | 0.00 | (0.36) | 4.39 | (5.40) | 9.08 | |
| CDTX | Cidara Therapeutics | 0.00 | 0 per month | 1.03 | 0.11 | 5.16 | (3.77) | 105.72 | |
| LEGN | Legend Biotech Corp | 0.00 | 0 per month | 0.00 | (0.22) | 3.51 | (4.83) | 12.55 |
Surgery Partners Additional Predictive Modules
Most predictive techniques to examine Surgery price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Surgery using various technical indicators. When you analyze Surgery charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Surgery Partners Predictive Indicators
The successful prediction of Surgery Partners stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Surgery Partners, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Surgery Partners based on analysis of Surgery Partners hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Surgery Partners's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Surgery Partners's related companies.
Story Coverage note for Surgery Partners
The number of cover stories for Surgery Partners depends on current market conditions and Surgery Partners' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Surgery Partners is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Surgery Partners' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Surgery Partners Short Properties
Surgery Partners' future price predictability will typically decrease when Surgery Partners' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Surgery Partners often depends not only on the future outlook of the potential Surgery Partners' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Surgery Partners' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 126.1 M | |
| Cash And Short Term Investments | 269.5 M |
Additional Tools for Surgery Stock Analysis
When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.